Business · 04/12/2013Updated: 10/17/2026 · 1 min read
FDA Announces Proposed Collection of Information for Review and Clearance Under Paperwork Reduction Act
Summary
The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, to report biological product deviations and human cells, tissues, and cellular and tissue-based product deviations in manufacturing.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →